✦ LIBER ✦

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)

✍ Scribed by Lorigan, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-90 Randomised phase III trial of docet

✍ Booton, Richard; Ascroft, Linda; Stout, Ron; Lorigan, Paul; Faivre-Finn, Corinne 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

22 Costs of cisplatin and carboplatin in

✍ Gaunt, P.; Frew, E.; Jarrett, H.; Billingham, L.; Ferry, D.; Dunlop, D.; Thompso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB

A randomized phase III trial of the Sout

✍ Galetta, D; Gebbia, V; Riccardi, F; Borsellino, N; Gridelli, C; Testa, A; Durini 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Bolus versus 5-day continuous infusion o

✍ C. Boni; L. Savoldi; G. Bisagni; G. Ceci; L. Crinò; V. De Lisi; F. Di Costanzo; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 84 KB

A phase II trial of individualized respo

✍ Shinbo, T; Makino, M; Tsukada, H; Yokoyama, A; Saitou, M; Kurita, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 230 KB

O-086a Randomized phase II/III trial of

✍ Sandler, A.B.; Gray, R.; Brahmer, J.; Dowlati, A.; Schiller, J.H.; Perry, M.C.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB